Stories - Corcept Therapeutics

Stories and perspectives.

Featured Stories

We are Corcept.

Founding Corcept

Turning Pain into Purpose and Leaving her Mark: Rachel’s Journey with Ovarian Cancer

All Stories

Corcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes

Press Release: Dec 14, 2024

‘Constantly stressed out’: A woman’s battle with excess cortisol

Honoring Ildaura Murillo-Rohde

Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes

Navigating Hypercortisolism: Deile’s Story

Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions

Press Release: Jun 24, 2024

Celebrating Dr. Neena Schwartz

Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)

Press Release: May 28, 2024

What is Hypercortisolism?

Featured Content: